A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models

Published:2019-08-12 Issue:2 Volume:371 Page:231-241
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Kuo Joseph,Bobardt Michael,Chatterji Udayan,Mayo Patrick R.,Trepanier Daniel J.,Foster Robert T.,Gallay Philippe,Ure Daren R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference66 articles.

1. Cyclophilin D and myocardial ischemia–reperfusion injury: A fresh perspective

2. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma;Baglieri;Int J Mol Sci,2019

3. BC Transplant Provincial Health Services Authority (2019) BC clinical guidelines for transplant medications.

4. Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis;Bigi;Oncogene,2016

5. Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions;Brichkina;Cell Death Differ,2016

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophilin inhibition as a strategy for the treatment of human disease;Frontiers in Pharmacology;2024-07-08

2. A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex;EMBO Reports;2024-06-28

3. Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B;JCI Insight;2024-06-20

4. Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH;PLOS ONE;2024-04-04

5. Role of the mitochondrial protein cyclophilin D in skin wound healing and collagen secretion;JCI Insight;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3